Biostatistics

Founded by biostatisticians in 1977, we’ve always been statistics-driven. Today, we have more than 90 biostatisticians at Emmes spread across the globe. Our biostatisticians have advanced degrees, including around a third with PhD’s in statistics, biostatistics, or epidemiology.

Our biostatisticians can optimize your study’s design and performance through advanced statistical approaches, innovative adaptive study designs and sophisticated analytical methodologies, then build them into your trial’s Statistical Analysis Plan.

In addition, our legacy in biostatistics has ensured that biostatistical input is embedded into all aspects of the clinical trial life cycle at Emmes and our close collaboration with clinical operations and data management ensures the right data is being collected in a high quality manner allowing for efficient analysis and reporting as well as ease of interpretation.

And our bioinformatics experts can deliver a variety of solutions when your trial involves analysis of large volumes of “omics” data analysis. Those include machine learning, advanced data visualization, clinical trial data management, pathways analysis, scalable cloud computing and reproducible data analysis methods.

All of this expertise has already helped to cure rare diseases and provide better patient treatments.

Together, we can optimize your trial, data quality and study results, from initial study planning to protocol writing, study design through regulatory submissions and publications.